Epirubicin Market Comprehensive Analysis and Future Estimations by 2028

The global Epirubicin market is expected to reach 243.99 million by 2028 from US$ 191.66 million in 2021. The market is estimated to grow at a CAGR of 3.60% from 2022 to 2028.

Epirubicin hydrochloride is a class of drugs termed anthracyclines and is primarily used to treat breast cancers after surgical resection. Anthracyclines are antibiotics isolated from the gram-positive bacteria Streptomyces. They are commonly used as chemotherapy agents and exert their antineoplastic effects by targeting the replication of DNA. Epirubicin HCl is often preferred over anthracycline doxorubicin as it has been shown to have fewer side effects. Epirubicin HCl became FDA-approved (Food and Drug Administration) as adjuvant therapy for treating axillary node-positive breast cancers following resection under the trade name Ellence in 1999.

Get a Sample PDF of report at- https://www.premiummarketinsights.com/sample/TIP00073584?utm_source=OpenPr&utm_medium=10640
(Kindly Use Corporate Mail ID To Get More Details)

The List of Companies -
1. Pfizer, Inc.
2. Teva Pharmaceutical Industries Ltd.
3. Salius Pharma Pvt Ltd
4. Areva Pharmaceuticals Mylan N. V.
5. Hikma Pharmaceuticals PLC
6. Fresenius Kabi AG
7. Miracalus Pharma Pvt. Ltd.

Also, the pharmaceutical industry in the UK is continuously expanding. Under the UK's pharmaceutical industry, over 610 companies are operating. According to Office National Statistics, 610 companies were operating in the UK in 2018. It has over 15 global companies headquartered in the UK. Also, nearly 41% of pharmaceutical production is exported to other countries and regions. Companies such as Astra Zeneca, Eli Lilly, and GSK have contributed significantly to the growth of pharmaceuticals and led research and development at a peak. The growth of these companies and expansions in the business segments are expected to influence market growth in the coming years.

In August 2020, the Government of India announced a program called Atmanirbhar Bharat, which means self-reliant India, as financial support to grow the pharmaceutical industry. Like the US and Europe, India has adopted independent manufacturing of pharmaceutical raw materials. Additionally, US$ 1.8 billion have been allocated for Production Linked Incentive Scheme (PLI) program for pharmaceuticals. This has provided an opportunity for India to become a global hub for the pharmaceutical & medical device industry. Nearly 30% of the investments are offered to the pharmaceutical industry to produce raw materials and intermediates essential to make antibiotics, analgesics, and other active pharmaceutical ingredients (API) .

Get Full Report: https://www.premiummarketinsights.com/reports-tip/epirubicin-market

The growing pharmaceutical industry worldwide is also likely to create growth opportunities for the epirubicin market. The US pharmaceutical market is the largest and the most commercial market in North America. The US alone holds over 45% of the global pharmaceutical market. The majority of the top global drug manufacturing companies are from the US, and the nation has been at the forefront of biomedical research.

Further, the pharmaceutical market in Germany holds the fourth position in the global pharmaceutical market with small and mid-sized companies. According to the International Trade Administration (ITA), in 2019, the pharmaceutical market in Germany accounted for US$ 62.5 billion. The country is likely to remain one of the most attractive destinations for the global pharmaceutical industry in the coming years in terms of manufacturing and supply. The market is driven by factors such as increasing investment in research and development and growing patent applications.

Buy Now: https://www.premiummarketinsights.com/buy/TIP00073584?utm_source=OpenPr&utm_medium=10640

TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Epirubicin Market - By Dosage
1.3.2 Global Epirubicin Market - By Application
1.3.3 Global Epirubicin Market - By Distribution Channel
1.3.4 Global Epirubicin Market - By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Epirubicin Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East And Africa PEST Analysis
4.2.5 South And Central America PEST Analysis
4.3 Experts Opinion
5. Epirubicin Market- Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Prevalence of Cancer
5.1.2 Increasing Awareness Regarding Cancer
5.2 Market Restraints
5.2.1 Elevated Risk of Adverse Effects due to Epirubicin
5.3 Market Opportunities
5.3.1 Rising FDA Approvals for Cancer Drugs
5.4 Future Trends
5.4.1 Increase in Number of Cancer Research Programs
5.5 Impact Analysis
6. Epirubicin Market- Global Analysis
6.1 Global Epirubicin Market Revenue Forecasts and Analysis
6.2 Global Epirubicin Market, By Geography - Forecasts And Analysis
6.3 Global Epirubicin Market - Market Potential Analysis, By Region
6.4 Company Analysis
6.4.1 Market Positioning of Key Players
6.4.2 Comparative Company Analysis
6.5 Performance of Key Players
6.5.1 Pfizer, Inc.
6.5.2 Teva Pharmaceutical Industries Ltd.
7. Epirubicin Market Analysis - By Dosage
8. Epirubicin Market Analysis and Forecast to 2028 - Application
9. Epirubicin Market Analysis and Forecast to 2028 - Distribution Channel
10. Global Epirubicin Market - Geographic Analysis
Continued…

Other Report:

Cold Forming And Cold Heading Market Leading Competitors, Regional Trends and Growth 2028 https://www.marketwatch.com/press-release/cold-forming-and-cold-heading-market-leading-competitors-regional-trends-and-growth-2028-2023-04-18?mod=search_headline

Lyophilized Injectable Market Global Industry Historical Background, Industry Structure, Development and Sector Opportunities Till 2028 https://www.marketwatch.com/press-release/lyophilized-injectable-market-global-industry-historical-background-industry-structure-development-and-sector-opportunities-till-2028-2023-04-18?mod=search_headline

Mindfulness Meditation Application Market In-depth Research with Industry Rapidly Boost in Future Forecast To 2028 https://www.marketwatch.com/press-release/mindfulness-meditation-application-market-in-depth-research-with-industry-rapidly-boost-in-future-forecast-to-2028-2023-04-18?mod=search_headline

Cerebral Aneurysm Clips Market Trends, Industry Share, Growth Drivers, Business Opportunities, and Demand Forecast to 2028 https://www.marketwatch.com/press-release/cerebral-aneurysm-clips-market-trends-industry-share-growth-drivers-business-opportunities-and-demand-forecast-to-2028-2023-04-18?mod=search_headline

Contact Us:
If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email: sales@premiummarketinsights.com

About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.

This release was published on openPR.